CN109280713A - 用于检测无细胞的病原体特异性核酸的方法和试剂盒 - Google Patents
用于检测无细胞的病原体特异性核酸的方法和试剂盒 Download PDFInfo
- Publication number
- CN109280713A CN109280713A CN201811203829.6A CN201811203829A CN109280713A CN 109280713 A CN109280713 A CN 109280713A CN 201811203829 A CN201811203829 A CN 201811203829A CN 109280713 A CN109280713 A CN 109280713A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- dna
- target nucleic
- double
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 94
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 79
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 54
- 230000001717 pathogenic effect Effects 0.000 title claims abstract description 33
- 244000052769 pathogen Species 0.000 title claims abstract description 32
- 108020004414 DNA Proteins 0.000 claims abstract description 92
- 239000008280 blood Substances 0.000 claims abstract description 36
- 210000004369 blood Anatomy 0.000 claims abstract description 35
- 102000053602 DNA Human genes 0.000 claims abstract description 30
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 20
- 239000000523 sample Substances 0.000 claims description 51
- 201000008827 tuberculosis Diseases 0.000 claims description 38
- 210000002381 plasma Anatomy 0.000 claims description 31
- 238000001514 detection method Methods 0.000 claims description 28
- 239000003153 chemical reaction reagent Substances 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 18
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 17
- 239000007850 fluorescent dye Substances 0.000 claims description 16
- 208000015181 infectious disease Diseases 0.000 claims description 16
- 238000003752 polymerase chain reaction Methods 0.000 claims description 15
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 8
- 238000003745 diagnosis Methods 0.000 claims description 7
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 claims description 6
- 101100509674 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) katG3 gene Proteins 0.000 claims description 6
- 101150092878 iniB gene Proteins 0.000 claims description 6
- 101150013110 katG gene Proteins 0.000 claims description 6
- 101150085857 rpo2 gene Proteins 0.000 claims description 6
- 101150090202 rpoB gene Proteins 0.000 claims description 6
- 101100381862 Bacillus subtilis (strain 168) bmr3 gene Proteins 0.000 claims description 5
- 101100344811 Starmerella bombicola mdr gene Proteins 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 238000001215 fluorescent labelling Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 20
- 238000003753 real-time PCR Methods 0.000 description 19
- 230000003321 amplification Effects 0.000 description 16
- 238000003199 nucleic acid amplification method Methods 0.000 description 16
- 239000012472 biological sample Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 10
- 208000002151 Pleural effusion Diseases 0.000 description 9
- 238000003759 clinical diagnosis Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 108010034145 Helminth Proteins Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 244000000013 helminth Species 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 4
- 108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 4
- 241000239226 Scorpiones Species 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000007834 ligase chain reaction Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 229960001005 tuberculin Drugs 0.000 description 3
- 241000224489 Amoeba Species 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 241000242711 Fasciola hepatica Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 241000239183 Filaria Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 208000032420 Latent Infection Diseases 0.000 description 2
- 206010065048 Latent tuberculosis Diseases 0.000 description 2
- 241000222722 Leishmania <genus> Species 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241000282560 Macaca mulatta Species 0.000 description 2
- 241000009328 Perro Species 0.000 description 2
- 241000224016 Plasmodium Species 0.000 description 2
- 241001442514 Schistosomatidae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241001502500 Trichomonadida Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000036981 active tuberculosis Diseases 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000004910 pleural fluid Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 241000190178 Cercomonas Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000186581 Clostridium novyi Species 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000224467 Giardia intestinalis Species 0.000 description 1
- 108010093628 Heterometrus granulomanus lectin Proteins 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000186362 Mycobacterium leprae Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588650 Neisseria meningitidis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000500086 Pseudorasbora parva Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 241000217239 Schizotrypanum Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- 101000832077 Xenopus laevis Dapper 1-A Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940085435 giardia lamblia Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 101150014428 mpt64 gene Proteins 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 235000019722 synbiotics Nutrition 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161470774P | 2011-04-01 | 2011-04-01 | |
| US61/470,774 | 2011-04-01 | ||
| CN201280026842.3A CN103814139B (zh) | 2011-04-01 | 2012-04-02 | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280026842.3A Division CN103814139B (zh) | 2011-04-01 | 2012-04-02 | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109280713A true CN109280713A (zh) | 2019-01-29 |
Family
ID=46932429
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811203829.6A Pending CN109280713A (zh) | 2011-04-01 | 2012-04-02 | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 |
| CN201280026842.3A Expired - Fee Related CN103814139B (zh) | 2011-04-01 | 2012-04-02 | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280026842.3A Expired - Fee Related CN103814139B (zh) | 2011-04-01 | 2012-04-02 | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20140147851A1 (enExample) |
| EP (1) | EP2694680A4 (enExample) |
| JP (2) | JP6430826B2 (enExample) |
| CN (2) | CN109280713A (enExample) |
| AU (3) | AU2012236109A1 (enExample) |
| RU (1) | RU2644672C2 (enExample) |
| WO (1) | WO2012135815A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114480691A (zh) * | 2022-01-24 | 2022-05-13 | 广州迪澳基因科技有限公司 | 基于熔解曲线检测结核分枝杆菌复合菌群的方法及试剂盒 |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012135815A2 (en) * | 2011-04-01 | 2012-10-04 | Occam Biolabs, Inc. | Methods and kits for detecting cell-free pathogen-specific nucleic acids |
| KR101780916B1 (ko) * | 2011-09-30 | 2017-09-21 | 인텔 코포레이션 | 집적회로 구조 및 집적회로 구조의 제조 방법 |
| EP3003561B1 (en) | 2013-05-24 | 2018-12-19 | Occam Biolabs, Inc. | System and method for collecting a sample of nucleic acid |
| US9644232B2 (en) * | 2013-07-26 | 2017-05-09 | General Electric Company | Method and device for collection and amplification of circulating nucleic acids |
| JP7451070B2 (ja) | 2013-11-07 | 2024-03-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ヒトミクロビオームおよびその成分の分析のための無細胞核酸 |
| CN104894226A (zh) * | 2014-03-07 | 2015-09-09 | 复旦大学 | 检测实验室结核分枝杆菌微环境表面污染的方法及其检测试剂盒 |
| CN107249746B (zh) | 2014-11-21 | 2020-05-15 | 澳康姆生物实验室公司 | 用于收集核酸样本的系统和方法 |
| AU2016264102A1 (en) | 2015-05-18 | 2017-12-21 | Karius, Inc. | Compositions and methods for enriching populations of nucleic acids |
| ES2912965T3 (es) | 2015-09-09 | 2022-05-30 | Drawbridge Health Inc | Dispositivos para la recopilación, estabilización y conservación de muestras |
| EP3141612A1 (en) | 2015-09-10 | 2017-03-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condtion, especially a health condition and/or pathogenic condition of a sample |
| WO2017077999A1 (ja) * | 2015-11-06 | 2017-05-11 | 公立大学法人横浜市立大学 | 結核菌群由来ｄｎａの検出方法 |
| CN105296661A (zh) * | 2015-12-02 | 2016-02-03 | 北京市结核病胸部肿瘤研究所 | 通过检测游离核酸诊断结核病的试剂盒及其应用 |
| KR102326769B1 (ko) | 2016-03-25 | 2021-11-17 | 카리우스, 인코포레이티드 | 합성 핵산 스파이크-인 |
| JP6812431B2 (ja) * | 2016-07-05 | 2021-01-13 | 株式会社日立製作所 | Ｄｎａ検出方法およびそのための装置 |
| JP7155136B2 (ja) | 2016-11-11 | 2022-10-18 | バイオ－ラド ラボラトリーズ，インコーポレイティド | 核酸試料をプロセシングする方法 |
| SG10201913371SA (en) * | 2017-01-30 | 2020-03-30 | Safeguard Biosystems Holdings Ltd | Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms |
| CA3059370C (en) | 2017-04-12 | 2022-05-10 | Karius, Inc. | Methods for concurrent analysis of dna and rna in mixed samples |
| CN108165562B (zh) * | 2017-12-01 | 2021-06-08 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv编码基因及其应用 |
| CN108165563B (zh) * | 2017-12-01 | 2021-02-19 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv编码基因及其应用 |
| CN108165561B (zh) * | 2017-12-01 | 2021-06-18 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv编码基因及其应用 |
| CN108165560B (zh) * | 2017-12-01 | 2021-06-08 | 北京蛋白质组研究中心 | 结核分枝杆菌H37Rv编码基因及其应用 |
| WO2019178157A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
| CA3118990A1 (en) | 2018-11-21 | 2020-05-28 | Karius, Inc. | Direct-to-library methods, systems, and compositions |
| CN111876411A (zh) * | 2019-09-06 | 2020-11-03 | 深圳微伴生物有限公司 | 获得cfDNA标准品的引物组、PCR扩增阳性标准品及其制备方法、试剂盒及应用 |
| KR102286570B1 (ko) * | 2019-11-19 | 2021-08-05 | 대한민국 | 소변 시료를 이용하여 결핵 진단용 프라이머, 프로브, 키트 및 이들의 용도 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307355A (zh) * | 2007-11-30 | 2008-11-19 | 亚洲基因科技股份有限公司 | 检测结核分支杆菌和非结核分支杆菌核酸扩增产物的试纸与方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0528306B1 (en) * | 1991-08-15 | 1999-11-17 | F. Hoffmann-La Roche Ag | Mycobacterium primer pair |
| US6458366B1 (en) * | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| EP0975807B1 (en) * | 1997-05-02 | 2006-09-27 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| DE19752898A1 (de) * | 1997-11-28 | 1999-08-05 | Centeon Pharma Gmbh | Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion |
| US6951722B2 (en) * | 1999-03-19 | 2005-10-04 | Takara Bio Inc. | Method for amplifying nucleic acid sequence |
| TWI237695B (en) * | 1999-12-14 | 2005-08-11 | Joy Biomedical Corp | Helicobacter pylori antigens in blood |
| WO2002008423A2 (en) * | 2000-07-24 | 2002-01-31 | Inpharmatica Limited | Adhesion molecules |
| CN1388378A (zh) * | 2002-06-17 | 2003-01-01 | 四川大学 | 结核分枝杆菌诊断检测试剂 |
| AU2004315186B2 (en) * | 2004-02-03 | 2008-03-13 | Bioneer Corporation | High throughput device for performing continuous-flow reactions |
| WO2006088895A2 (en) * | 2005-02-17 | 2006-08-24 | Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani | Compositions and methods for detecting pathogen specific nucleic acids in urine |
| JP2009515545A (ja) * | 2005-11-15 | 2009-04-16 | ジェノイド・ケーエフティー | 方法 |
| US8741565B2 (en) * | 2005-12-30 | 2014-06-03 | Honeywell International Inc. | Oligonucleotide microarray for identification of pathogens |
| US8029806B2 (en) * | 2008-04-16 | 2011-10-04 | Asiagen Corporation | Method for diagnosing of Mycobacterium tuberculosis |
| CA2748822C (en) * | 2009-01-06 | 2016-09-06 | Qimin You | Cross priming amplification of target nucleic acids |
| WO2012135815A2 (en) * | 2011-04-01 | 2012-10-04 | Occam Biolabs, Inc. | Methods and kits for detecting cell-free pathogen-specific nucleic acids |
-
2012
- 2012-04-02 WO PCT/US2012/031814 patent/WO2012135815A2/en not_active Ceased
- 2012-04-02 CN CN201811203829.6A patent/CN109280713A/zh active Pending
- 2012-04-02 US US14/009,199 patent/US20140147851A1/en not_active Abandoned
- 2012-04-02 EP EP12765867.2A patent/EP2694680A4/en not_active Withdrawn
- 2012-04-02 RU RU2013148806A patent/RU2644672C2/ru not_active IP Right Cessation
- 2012-04-02 CN CN201280026842.3A patent/CN103814139B/zh not_active Expired - Fee Related
- 2012-04-02 AU AU2012236109A patent/AU2012236109A1/en not_active Abandoned
- 2012-04-02 JP JP2014502902A patent/JP6430826B2/ja not_active Expired - Fee Related
-
2017
- 2017-05-09 AU AU2017203071A patent/AU2017203071A1/en not_active Abandoned
- 2017-07-31 US US15/664,074 patent/US20170369932A1/en not_active Abandoned
-
2018
- 2018-05-10 JP JP2018091537A patent/JP2018117645A/ja active Pending
-
2019
- 2019-07-05 AU AU2019204844A patent/AU2019204844A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307355A (zh) * | 2007-11-30 | 2008-11-19 | 亚洲基因科技股份有限公司 | 检测结核分支杆菌和非结核分支杆菌核酸扩增产物的试纸与方法 |
Non-Patent Citations (3)
| Title |
|---|
| JOU, NT等: "Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis", 《JOURNAL OF CLINICAL MICROBIOLOGY》 * |
| ROSSETTI, MLR等: "Improvement of Mycobacterium tuberculosis detection in clinical samples using DNA purified by glass matrix", 《JOURNAL OF MICROBIOLOGICAL METHODS》 * |
| STADEN等: "Detection of Mycobacterium tuberculosis in serum samples using the polymerase chain reaction", 《JOURNAL OF INFECTION》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114480691A (zh) * | 2022-01-24 | 2022-05-13 | 广州迪澳基因科技有限公司 | 基于熔解曲线检测结核分枝杆菌复合菌群的方法及试剂盒 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103814139A (zh) | 2014-05-21 |
| CN103814139B (zh) | 2018-11-13 |
| JP6430826B2 (ja) | 2018-11-28 |
| EP2694680A2 (en) | 2014-02-12 |
| JP2014510538A (ja) | 2014-05-01 |
| EP2694680A4 (en) | 2014-09-10 |
| US20170369932A1 (en) | 2017-12-28 |
| AU2019204844A1 (en) | 2019-07-25 |
| WO2012135815A2 (en) | 2012-10-04 |
| RU2013148806A (ru) | 2015-05-10 |
| JP2018117645A (ja) | 2018-08-02 |
| AU2017203071A1 (en) | 2017-06-01 |
| WO2012135815A3 (en) | 2012-12-27 |
| US20140147851A1 (en) | 2014-05-29 |
| AU2012236109A1 (en) | 2013-11-21 |
| RU2644672C2 (ru) | 2018-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109280713A (zh) | 用于检测无细胞的病原体特异性核酸的方法和试剂盒 | |
| Kuk et al. | Stool sample storage conditions for the preservation of Giardia intestinalis DNA | |
| CN107586862B (zh) | 肠道菌群在儿童反复呼吸道感染诊断中的应用 | |
| Zhang et al. | A highly sensitive and versatile fluorescent biosensor for pathogen nucleic acid detection based on toehold-mediated strand displacement initiated primer exchange reaction | |
| CN111172306A (zh) | 一种用于检测结核分枝杆菌和/或布鲁氏菌的组合物、试剂盒及其应用 | |
| CN119372346A (zh) | 一种用于检测布鲁氏菌属的双链探针辅助的环介导等温扩增系统 | |
| CN106916903A (zh) | 结核分枝杆菌85B mRNA的实时荧光RT‑PCR检测方法及试剂盒 | |
| CN102229999A (zh) | 鉴别结核和非结核分枝杆菌的试剂盒及其使用方法 | |
| CN108350508B (zh) | 雌马酚产生能力的测定方法 | |
| US10131956B2 (en) | Marker used for detection of colon cancer, and application thereof | |
| CN115852004A (zh) | 一种表皮葡萄球菌的病原体特异性核酸基因及检测方法 | |
| WO2013049822A2 (en) | Diagnostic method for determining animals persistently infected (pi) with bovine viral diarrhea virus (bvdv) | |
| JP7599756B2 (ja) | 結核感染試料のスクリーニング方法及びこれに用いるプローブセット | |
| WO2021261373A1 (ja) | 結核感染試料のスクリーニング方法並びにこれに用いるバイオマーカー及びプローブセット | |
| US20230167510A1 (en) | Universal primers for detection of bacteria, fungi and eukaryotic microorganisms | |
| Munir et al. | Diagnosis of tuberculosis: molecular versus conventional method | |
| CN102925541B (zh) | 一种检测结核潜伏感染状态的方法和试剂盒 | |
| WO2024262092A1 (en) | Analytical methods, kit and devices for cancer diagnosis by means of micrornas | |
| CN111197094B (zh) | 用于副溶血弧菌基因分型的组合物、试剂盒和方法 | |
| HK40003844A (en) | Methods and kits for detecting cell-free pathogen-specific nucleic acids | |
| KR20110116644A (ko) | 결핵의 진단을 위한 정보제공방법 및 이를 위한 결핵 진단용 키트 | |
| OA21814A (en) | Method for screening tuberculosisinfected sample and probe set to be used therefor. | |
| KR102131519B1 (ko) | 간암 전이 진단 또는 예후 예측용 바이오마커 및 이의 용도 | |
| CN118726622A (zh) | 一种基于TtAgo的幽门螺杆菌等温扩增一管式检测用组合物、试剂盒和检测方法 | |
| JPWO2021125105A1 (ja) | 分析方法及びキット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40003844 Country of ref document: HK |
|
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190129 |
|
| WD01 | Invention patent application deemed withdrawn after publication |